卡铂
医学
剜除术
视网膜母细胞瘤
外科
化疗
依托泊苷
放射治疗
外照射放疗
顺铂
眼科
近距离放射治疗
生物化学
基因
化学
作者
A. Linn Murphree,J. G. Villablanca,William Deegan,Judith K. Sato,Marcio H. Malogolowkin,Alan Fisher,Richard Parker,E Reed,Charles J. Gomer
出处
期刊:Archives of Ophthalmology
[American Medical Association]
日期:1996-11-01
卷期号:114 (11): 1348-1348
被引量:469
标识
DOI:10.1001/archopht.1996.01100140548005
摘要
Thermochemotherapy is successful primary treatment for Reese-Ellsworth group 1 and 2 retinoblastomas. For larger tumors in the absence of vitreous or extensive subretinal seeding, 3 cycles of chemoreduction followed by SALT eradicates residual viable tumor. Chemoreduction plus SALT was not successful in eyes with diffuse vitreous or extensive subretinal seeding. Prior chemotherapy increases the risk for radiation retinopathy following 125I plaque therapy. External beam radiotherapy can safely be avoided in the primary treatment of Reese-Ellsworth groups 1 through 4 nondispersed retinoblastoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI